Beckman Coulter Life Sciences Names Joe Fox President
Advertisement
Beckman Coulter Life Sciences announces the appointment of Joe Fox as President of the company effective immediately. Fox joins Beckman Coulter Life Sciences from SCIEX, also an Operating Company of Danaher Corporation, where he held positions of increasing responsibility over the past 13 years, most recently serving as President.
Joe Fox
Beckman Coulter Life Sciences
“Joe is a proven leader with a strong track record of successfully growing businesses and building diverse, inclusive and engaged teams in the life science and clinical industries,” said Greg Milosevich, Vice President and Group Executive of the Danaher Life Sciences Innovations Group. “He uniquely understands our strategy, culture of our Danaher Business System (DBS), and has a strong commitment to customer excellence. Joe will help Beckman Coulter Life Sciences continue to deliver meaningful innovation while developing and attracting top talent.”
“This is a pivotal time in the life sciences industry with many life-saving breakthroughs on the edge of discovery, all while many laboratories are navigating unique challenges,” said Fox. “At Beckman Coulter Life Sciences, our passion is solving customer problems. We will lead the way with customizable, sustainable solutions that accelerate and simplify complex workflows in service to our customers. Together, we’ll tackle global health challenges, revolutionize healthcare, and elevate patient care.”
Fox will lead a global team of more than 3,300 associates, driving product and service innovation to deliver workflow solutions in areas including Centrifugation, Flow Cytometry, Genomics, Particle Analysis, and Liquid Handling. He will also champion the Beckman Coulter Life Sciences commitment to sustainability which includes further integrating sustainability into operations, products, and packaging.
Prior to joining SCIEX, Fox held both technical and commercial roles with Bruker and Shimadzu. He holds a Bachelor of Science Degree in Biochemistry from the University of Delaware and a Ph.D. in Chemistry from Johns Hopkins University.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
Nobel Prize in Medicine for immune system guardians - Two Americans and one Japanese scientist honored for revolutionary discoveries on the balance of the immune system in autoimmune diseases
GEA Supervisory Board takes early decision to extend contract of CEO Stefan Klebert - Company resolves to restructure the Executive Board and streamline the organizational structure as of January 1, 2026
Mosaic Therapeutics appoints Thomas Fuchs as CEO - Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadership
WIKA strengthens management team with Axel Schwerdtfeger - Process Solutions company division under new leadership
Otto Warburg Medal 2026 awarded to Maya Schuldiner
Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration - Agreement to take on real-world challenges in biologics and materials research
New biotech venture PHIOGEN to tackle the global threat of antimicrobial resistance - By optimizing nature’s defenders, the team has produced unprecedented phage treatments
CureVac and MD Anderson enter strategic collaboration to develop novel cancer vaccines - Collaboration aims to develop novel, off-the-shelf, mRNA-based cancer vaccines in selected hematological and solid cancers with high unmet medical need
First-of-its-kind vaccine expands malaria protection for pregnant women - Sanaria® PfSPZ Vaccine protects women against malaria before and during pregnancy for at least two years
